|
CCNYL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.719700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.746400E-02 |
| Normal-vs-Stage2 |
8.218200E-01 |
| Normal-vs-Stage3 |
1.929750E-01 |
| Normal-vs-Stage4 |
5.510300E-02 |
| Stage1-vs-Stage2 |
3.965600E-01 |
| Stage1-vs-Stage3 |
9.429800E-01 |
| Stage1-vs-Stage4 |
7.427800E-01 |
| Stage2-vs-Stage3 |
5.409200E-01 |
| Stage2-vs-Stage4 |
3.768400E-01 |
| Stage3-vs-Stage4 |
7.115200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.796400E-02 |
| Normal-vs-AfricanAmerican |
2.141600E-01 |
| Normal-vs-Asian |
4.963800E-01 |
| Caucasian-vs-AfricanAmerican |
9.524600E-01 |
| Caucasian-vs-Asian |
8.788000E-01 |
| AfricanAmerican-vs-Asian |
8.637000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.206200E-02 |
| Normal-vs-Female |
9.724400E-01 |
| Male-vs-Female |
1.704590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.973300E-04 |
| Normal-vs-Extreme_Weight |
1.299990E-02 |
| Normal-vs-Obese |
4.336600E-01 |
| Normal-vs-Extreme_Obese |
7.420000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.574800E-01 |
| Normal_Weight-vs-Obese |
4.197700E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.543400E-01 |
| Extreme_Weight-vs-Obese |
2.502000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.651800E-01 |
| Obese-vs-Extreme_Obese |
3.158200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.971800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.497200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.162600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.646600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.674000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.134600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.166000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.330400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.768600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.604600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.927200E-01 |
| Normal-VS-Type2 PRCC |
8.01480000000021E-05 |
| Normal-VS-KIRP CIMP |
2.455200E-01 |
| Normal-VS-Unclassified PRCC |
3.922000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.003500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.803600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.413400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.895100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.421960E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.306400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.997600E-03 |
| Normal-vs-N1 |
3.762200E-01 |
| Normal-vs-N2 |
1.641620E-02 |
| N0-vs-N1 |
2.112400E-01 |
| N0-vs-N2 |
6.340400E-01 |
| N1-vs-N2 |
2.052000E-01 |
|
|
